Science News

group of older women outside arm in arm smiling

Clinicians Aren’t Talking to Women With HIV About Menopause

Vector illustration with a touch of 80’s style depicting COVID-19 concept

A Majority of People With HIV Have Asymptomatic COVID

Broadly Neutralizing Antibodies Delay HIV Rebound

Clinicians Aren’t Talking to Women With HIV About Menopause

A Majority of People With HIV Have Asymptomatic COVID

Broadly Neutralizing Antibodies Delay HIV Rebound

People With Lifelong HIV Are More Likely to Have Metabolic Problems

Older HIV drugs are in part to blame for the rising rate, but newer medications, like integrase inhibitors, are not.

Broadly Neutralizing Antibody Leads to Long-Term HIV Remission

One person treated with a broadly neutralizing antibody plus romidepsin remained in remission for 3.7 years.

3D model of SARS-CoV2 coronavirus (back) and its spike protein (front) that enables the virus to enter human cells.

Intranasal Proteins Could Protect Against COVID-19 Variants

With further testing, the antiviral proteins might be used as a nasal spray to prevent or treat COVID-19.

High Drug Copays Leave PrEP Prescriptions Unclaimed

PrEP prescriptions are supposed to be free to users now, which could go a long way toward leveling the HIV-prevention playing field.

Some Telehealth Programs Still Charge for HIV Prevention Pills

Telemedicine is an increasingly used to provide convenient PrEP services. But are these programs following U.S. guidelines?

MUST read

Gene Editing Delays Viral Rebound During HIV Treatment Interruption

Some People With HIV Don’t Adhere to Treatment to Save Money

There’s Never Been a Better Time to Get Pregnant If One of You Has HIV

POZ March 2019 cover U=U Undetectable = Untransmitable

Communicating Undetectable Equals Untransmittable

The Science Is Clear: With HIV, Undetectable Equals Untransmittable

4 in 5 HIV Transmissions Likely Come From Those Not in Care for the Virus

Still Few Answers as Kids Hepatitis Outbreak Spreads

Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.

Investigating the Connections Between Medicaid and Cancer Survival

When it comes to prevention, Medicaid also plays a role in lowering the burden of cancer among people living with HIV.

More Cardiac Abnormalities Seen in People Living With HIV

Baseline readings in the REPRIEVE study show sex and race differences in electrocardiograph outcomes.

Nasal Antiviral Blocks SARS-CoV-2 Infection in Mice

Antiviral drugs that target host cells may work against many existing and future variants of the virus that causes COVID-19.

Black Women Prefer HIV Prevention Shots, but Cost Is a Factor

Currently, fewer than 1 in 10 women eligible for HIV prevention medications are taking them.

Science News

Clinicians Aren’t Talking to Women With HIV About Menopause

A Majority of People With HIV Have Asymptomatic COVID

Broadly Neutralizing Antibodies Delay HIV Rebound

MUST read

Gene Editing Delays Viral Rebound During HIV Treatment Interruption

Some People With HIV Don’t Adhere to Treatment to Save Money

There’s Never Been a Better Time to Get Pregnant If One of You Has HIV

Communicating Undetectable Equals Untransmittable

The Science Is Clear: With HIV, Undetectable Equals Untransmittable

4 in 5 HIV Transmissions Likely Come From Those Not in Care for the Virus

Hot topics

#Cure

#Long-Term Survivors

#Prevention

#PrEP

Features

Newsfeed

Hot topics

Forums: Support and discussion

Blogs: The community speaks

POZ Stories: Get inspired

Magazine: Search the archives

HIV: The Basics

Recursos de VIH/SIDA en Español

AIDS Is Everyday

Ask POZ